v3.25.1

Summary of significant transactions - Revised Fligotinib collaboration (Details) - Gilead - Filgotinib drug license € in Millions | Dec. 31, 2023 | Oct. 29, 2023 | Dec. 31, 2022 EUR (€) | Jan. 31, 2021
--- | --- | --- | --- | ---
Summary Of Significant Transaction [line items] |  |  |  |
Total Amounts Received From Gilead In Previous Years |  |  | € 172.6 |
Cost Share For Global Development Activities Terminated |  | 50.00% |  |
Europe | Minimum |  |  |  |
Summary Of Significant Transaction [line items] |  |  |  |
Percentage of future net sales from 2024 | 8 |  |  |
Europe | Maximum |  |  |  |
Summary Of Significant Transaction [line items] |  |  |  |
Percentage of future net sales from 2024 | 15 |  |  |
Group B activities [Member] |  |  |  |
Summary Of Significant Transaction [line items] |  |  |  |
Cost Share For Global Development Activities |  |  |  | 50.00%

X
- Definition It represents the cost share mechanism for the future development activities, development and sales milestones and royalties. + References No definition available. + Details
Name: | glpg_CostShareForGlobalDevelopmentActivities
Namespace Prefix: | glpg_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition It represents the cost share mechanism for the future development activities, development and sales milestones and royalties that was terminated. + References No definition available. + Details
Name: | glpg_CostShareForGlobalDevelopmentActivitiesTerminated
Namespace Prefix: | glpg_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition The percentage of the entity's net sales in future years. + References No definition available. + Details
Name: | glpg_PercentageOfFutureNetSalesFrom2024
Namespace Prefix: | glpg_
Data Type: | xbrli:pureItemType
Balance Type: | na
Period Type: | instant

X
- Definition Line items represent summary of significant transaction. + References No definition available. + Details
Name: | glpg_SummaryOfSignificantTransactionLineItems
Namespace Prefix: | glpg_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The total amount received from Gilead in previous years. + References No definition available. + Details
Name: | glpg_TotalAmountsReceivedFromGileadInPreviousYears
Namespace Prefix: | glpg_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Details
Name: | ifrs-full_CounterpartiesAxis=glpg_GileadMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_ProductsAndServicesAxis=glpg_FilgotinibDrugLicenseMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_StatementGeographicalAxis=srt_EuropeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfContractsAxis=glpg_GroupBActivitiesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |